Teva Pharmaceuticals USA, Inc. v. Merck Sharp & Dohme Corp. > Summary
Court Case Number IPR2020-01045
Filing Date Jun 10, 2020
Institution Decision Date Sep 1, 2020
Decision Date Dec 8, 2020
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesTimothy G. Majors, Sheridan K. Snedden, Robert A. Pollock
Judge Writing the Final DecisionTimothy G. Majors
Claims Challenged in the Petition: 1, 2, 3, 4, 17, 19, 21, 22, 23
Claims Instituted: 1, 2, 3, 4, 17, 19, 21, 22, 23
Petitioner
Patent Owner
Petitioner Attorneys
6Teva Pharmaceuticals
Attorney Name: Keith A. Zullow
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Sarah J. Fischer
Goodwin Procter LLP
Teva Pharmaceuticals
Attorney Name: Emily L. Rapalino
Goodwin Procter LLP
Attorney Name: Christopher W. West
Katten Muchin Rosenman
Attorney Name: Heike S. Radeke
Katten Muchin Rosenman
Attorney Name: Alissa Marie Pacchioli
Katten Muchin Rosenman
Patent Owner Attorneys
8Merck Sharp & Dohme
Attorney Name: Stanley E. Fisher
Williams & Connolly
Merck Sharp & Dohme
Attorney Name: Jessamyn S. Berniker
Williams & Connolly
Merck Sharp & Dohme
Attorney Name: Bruce R. Genderson
Williams & Connolly
Merck Sharp & Dohme
Attorney Name: Shaun P. Mahaffy
Williams & Connolly
Merck Sharp & Dohme
Attorney Name: Anthony H. Sheh
Williams & Connolly
Merck Sharp & Dohme
Attorney Name: Alexander S. Zolan
Williams & Connolly
Merck Sharp & Dohme
Attorney Name: Elise M. Baumgarten
Williams & Connolly
Attorney Name: Philippe L. Durette
Merck & Co., Inc.
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07326708 | Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor | Feb 5, 2008 |
